Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.4.6 (
urease
)
7,490
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
UVB-induced immunosuppression, a promoter of photocarcinogenesis, involves the formation of pyrimidine dimers and cis-urocanic acid (cis-UCA), but reactive oxygen species (ROS) also plays an important role.
Eicosapentaenoic acid
(
EPA
) can inhibit photocarcinogenesis, but due to its polyunsaturated nature it is susceptible to oxidative damage by ROS. The antioxidant defense system may therefore be challenged upon ultraviolet-B (UVB) irradiation in the presence of
EPA
. We investigated whether topically applied
EPA
in mice could protect against local immunosuppression (contact hypersensitivity response to dinitrofluorobenzene) induced by UVB radiation (1.5 J/cm2), or topically applied cis-
UCA
(150 nmol/cm2) or thymidine dinucleotides (pTpT) (5 nmol/cm2). The influence of
EPA
on epidermal lipid peroxidation and antioxidant status was also measured. UVB irradiation, cis-
UCA
and pTpT all caused 70% immunosuppression. Topical pretreatment of mice with
EPA
partially protected against immunosuppression; the
EPA
dose needed to accomplish this was 10 nmol/cm2 for UVB irradiation, 100 nmol/cm2 for cis-
UCA
and 1000 nmol/cm2 for pTpT. Higher
EPA
doses caused higher UVB-induced lipid peroxidation and lower vitamin C levels. Glutathione only decreased with the highest
EPA
dose whereas vitamin E was not decreased after UVB irradiation. In conclusion, topically applied
EPA
protects against UVB-, cis-
UCA
- and pTpT-induced immunosuppression and maintenance of an adequate antioxidant defense seems to be an important prerequisite for the protective action by
EPA
.
...
PMID:Topically applied eicosapentaenoic acid protects against local immunosuppression induced by UVB irradiation, cis-urocanic acid and thymidine dinucleotides. 1120 68